{"subsection_name": null, "pub_date": "2011-10-03T09:20:01Z", "byline": {"original": "By PETER LATTMAN", "person": [{"lastname": "LATTMAN", "organization": "", "rank": 1, "role": "reported", "firstname": "Peter"}]}, "abstract": "The Carlyle Group and Hellman & Friedman agreed to buy Pharmaceutical Product Development in one of the largest private equity deals this year.", "word_count": 498, "print_page": null, "news_desk": null, "snippet": "The Carlyle Group and Hellman & Friedman agreed to buy Pharmaceutical Product Development in one of the largest private equity deals this year.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "organizations", "value": "Carlyle Group", "rank": "4"}, {"name": "subject", "value": "Private Equity", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "organizations", "value": "Hellman & Friedman", "rank": "5"}, {"name": "type_of_material", "value": "News", "rank": "1"}, {"name": "organizations", "value": "Pharmaceutical Product Development", "rank": "6"}, {"name": "unknown", "value": "Pharmaceutical Product Development|PPDI|NASDAQ", "rank": "7"}], "type_of_material": "Blog", "lead_paragraph": "7:02 p.m. | Updated", "web_url": "http://dealbook.nytimes.com/2011/10/03/carlyle-and-hellman-friedman-to-buy-ppd-for-3-9-billion/", "section_name": "Business Day", "headline": {"main": "Buyout Firms to Buy Drug Research Company for $3.9 Billion", "kicker": "DealBook"}, "slideshow_credits": null, "_id": "4fd3a1e48eb7c8105d8e92ad", "document_type": "blogpost"}